A comprehensive view of Catalent Inc.. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Catalent (CTLT) Q2 Earnings Lag Estimates, Revenues Top
Published: February 07, 2023 by Zack's Commentary
Catalent and Moderna to extend, expand manufacturing partnership; Catalent to continue Moderna COVID-19 programs, may extend partnership for flu, RSV vaccines, starting at Bloomington, Indiana, facility then expanding to Anagni, Italy, plant
Published: February 07, 2023 by Outsourcing-Pharma.com
J&J cuts COVID-19 vaccine production due to low demand, terminates manufacturing agreements with Catalent, Sanofi
Published: January 16, 2023 by CE NAFTA 2.0 Newswire (Mexico)
Catalent inks deal to manufacture Sarepta's DMD gene therapy to treat Duchenne muscular dystrophy; deal calls for Catalent to support multiple gene therapy candidates in Sarepta’s pipeline for limb-girdle muscular dystrophy
Published: January 06, 2023 by FiercePharma
Catalent lays off over 210 employees in Texas and Maryland, 400 people in Bloomington, Indiana, due to crash in revenue from COVID-19-related products
Published: December 02, 2022 by FiercePharma

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count